During the past decade, Queen Elizabeth II Health Sciences Centre; Oncology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 12 clinical trials were completed, i.e. on average, 171.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth II Health Sciences Centre; Oncology" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth II Health Sciences Centre; Oncology" are "Breast Cancer" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Lymphocytic Leukemia, Chronic" (2 trials), "Renal Cell Carcinoma" (2 trials) and "B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Queen Elizabeth II Health Sciences Centre; Oncology" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth II Health Sciences Centre; Oncology" are "Drug" (17 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (7 trials), "Placebo" (5 trials), "Doxorubicin" (4 trials), "Obinutuzumab" (4 trials) and "Rituximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth II Health Sciences Centre; Oncology" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Queen Elizabeth II Health Sciences Centre; Oncology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Queen Elizabeth II Health Sciences Centre; Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth II Health Sciences Centre; Oncology, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".